{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:08:50Z","timestamp":1787317730649,"version":"build-2736575974"},"reference-count":110,"publisher":"Informa UK Limited","issue":"18","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2025,12,12]]},"DOI":"10.1080\/14656566.2025.2610373","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T05:46:58Z","timestamp":1766641618000},"page":"1961-1972","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Reshaping multiple myeloma treatment: recent breakthroughs"],"prefix":"10.1080","volume":"26","author":[{"given":"Enrica Antonia","family":"Martino","sequence":"first","affiliation":[{"name":"AO of Cosenza","place":["Cosenza, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santino","family":"Caserta","sequence":"additional","affiliation":[{"name":"AO of Cosenza","place":["Cosenza, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Vigna","sequence":"additional","affiliation":[{"name":"AO of Cosenza","place":["Cosenza, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Bruzzese","sequence":"additional","affiliation":[{"name":"AO of Cosenza","place":["Cosenza, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Mendicino","sequence":"additional","affiliation":[{"name":"AO of Cosenza","place":["Cosenza, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eugenia","family":"Alvaro","sequence":"additional","affiliation":[{"name":"AO of Cosenza","place":["Cosenza, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Labanca","sequence":"additional","affiliation":[{"name":"AO of Cosenza","place":["Cosenza, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Lucia","sequence":"additional","affiliation":[{"name":"AO of Cosenza","place":["Cosenza, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Olivito","sequence":"additional","affiliation":[{"name":"AO of Cosenza","place":["Cosenza, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Amodio","sequence":"additional","affiliation":[{"name":"University of Catanzaro","place":["Catanzaro, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunato","family":"Morabito","sequence":"additional","affiliation":[{"name":"AIL Sezione di Cosenza","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Gentile","sequence":"additional","affiliation":[{"name":"AO of Cosenza","place":["Cosenza, Italy"]},{"name":"University of Calabria","place":["Rende, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1663522"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2023.2218543"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2023.2193289"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2022.2145882"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2016.1274973"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.105514"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14121"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14353"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00754-1"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0626"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30788-0"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00330-4"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(25)00256-X"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0347-5"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abg1209"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01338-6"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000970420.62475.d0"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02589-w"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02528-9"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2204591"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.287334"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2514752"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS8064"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-200181"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025029360"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2514663"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.7513"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-210520"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS7577"},{"key":"e_1_3_4_31_1","volume-title":"Talquetamab + Cetrelimab in patients with relapsed\/refractory multiple myeloma: initial safety and efficacy results from the phase 1B TRIMM-3 study","author":"Perrot A","year":"2025","unstructured":"Perrot A, Touzeau C, Rodr\u00edguez-Otero P, et al. Talquetamab + Cetrelimab in patients with relapsed\/refractory multiple myeloma: initial safety and efficacy results from the phase 1B TRIMM-3 study. EHA Library. 2025."},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-206003"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-159756"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.7504"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2025.11.004"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025987"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01504"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025030027"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.7505"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-199423"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-793869"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024850"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-162469"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-173970"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-178933"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00933-8"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.8009"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-178882"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015526"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303379"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(24)02346-2"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-146210"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2023000434"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02182-7"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18909"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-23-0049"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00879-7"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024015008"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10824-3"},{"key":"e_1_3_4_60_1","first-page":"705","article-title":"Anti-BCMA car T-cell therapy bb2121 in relapsed or refractory multiple myeloma","volume":"386","author":"Raje N","year":"2022","unstructured":"Raje N, Berdeja J, Lin Y, et al. Anti-BCMA car T-cell therapy bb2121 in relapsed or refractory multiple myeloma. N Engl J Med. 2022;386:705\u2013716.","journal-title":"N Engl J Med"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024850"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203478"},{"key":"e_1_3_4_63_1","first-page":"1234","article-title":"Access, outcomes, and toxicities of car T-cell therapy in real-world multiple myeloma","volume":"7","author":"Cohen AD","year":"2023","unstructured":"Cohen AD, Garfall AL, Stadtmauer EA, et al. Access, outcomes, and toxicities of car T-cell therapy in real-world multiple myeloma. Blood Adv. 2023;7:1234\u20131243.","journal-title":"Blood Adv"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1508675"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-019-01135-4"},{"key":"e_1_3_4_66_1","first-page":"1","article-title":"Clinical outcome and prognostic factors of autologous stem cell transplantation in multiple myeloma: a multicentre study from India","volume":"81","author":"Raja V","year":"2025","unstructured":"Raja V, et al. Clinical outcome and prognostic factors of autologous stem cell transplantation in multiple myeloma: a multicentre study from India. Med J Armed Forces India. 2025;81:1\u20138.","journal-title":"Med J Armed Forces India"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.76164"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30206-6"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00377-0"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00772-9"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.3160"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011101"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006731"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2025.006"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-168842"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01935"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024026230"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.2267"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-01893"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00776"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0196-8"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00611-x"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02614"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.133.5.813"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01226"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.08.024"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.219139"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-361386"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.280051"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1240966"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01696"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023023597"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.0638"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-795047"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01488-8"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817249"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2021.06.005"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-165524"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0311-8"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-128000"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402551"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03143"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009507"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00280-3"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.014"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024027342"},{"issue":"1","key":"e_1_3_4_107_1","first-page":"400","article-title":"Response-adapted lenalidomide maintenance in newly diagnosed, transplant-eligible multiple myeloma: results from the multicenter phase iii GMMG-MM5 trial","volume":"130","author":"Goldschmidt H","year":"2017","unstructured":"Goldschmidt H, Mai EK, Durig J, et al. Response-adapted lenalidomide maintenance in newly diagnosed, transplant-eligible multiple myeloma: results from the multicenter phase iii GMMG-MM5 trial. Blood. 2017;130(Suppl 1):400 (abstract).","journal-title":"Blood"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2025.2525457"},{"key":"e_1_3_4_109_1","first-page":"1","article-title":"Are we maintaining minimal residual disease in myeloma?","volume":"21","author":"Aljama MA","year":"2025","unstructured":"Aljama MA, Sidiqi HM, Gertz MA. Are we maintaining minimal residual disease in myeloma? Leuk Lymphoma. 2025;21:1\u20139.","journal-title":"Leuk Lymphoma"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-158643"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-156730"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2025.2610373","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:11:43Z","timestamp":1770271903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2025.2610373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":110,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025,12,12]]}},"alternative-id":["10.1080\/14656566.2025.2610373"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2025.2610373","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}